Kyowa Kirin Co Ltd's Fiscal Year is From January To December - All Figures are in JPY, Billions.
The item "Research-and-Development" stands at 106.80 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.
Kyowa Kirin Co Ltd's second quarter result of 23.94 Billion JPY for the item "Research and Development" represents a decrease of -16.16 percent compared to it's first quarter result.
Also, Kyowa Kirin Co Ltd's second quarter result of 23.94 Billion JPY for the item "Research and Development" represents a decrease of -7.66 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Kyowa Kirin Co Ltd's second quarter result of 106.80 Billion JPY for the item "Research and Development" represents a decrease of -1.82 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes an increase of 21.78 percent compared to the value the year prior.
The 1 year change in percent is 21.78.
The 3 year change in percent is 80.73.
The 5 year change in percent is 102.65.
The 10 year change in percent is 114.06.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Research and Development | 905,699,262,464.00 |
![]() | Johnson & Johnson - Research and Development | 486,508,953,600.00 |
![]() | AbbVie Inc - Research and Development | 399,570,305,024.00 |
![]() | Roche Holding AG - Research and Development | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Research and Development | 280,205,508,085.11 |